{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:40:25Z","timestamp":1792172425003,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypoxic-ischemic encephalopathy (HIE) remains a major cause of neonatal mortality and long-term neurodevelopmental disability. Intranasally delivered mesenchymal stem cells and neurotrophic factors from breast milk have been detected in the central nervous system and may have a role in neuroregenerative processes. F-NEO-BRIGHT (Feasibility- NEOnatal- intranasal BReast milk, Impact on brain Growth in HIE Therapy) is the first clinical study aimed to assess the feasibility and safety of intranasal fresh breast milk (iFBM) in neonates with HIE in both inpatient and home settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective, single-center study involved ten patients diagnosed with moderate to severe HIE treated with therapeutic hypothermia. Own-mother\u2019s fresh breast milk expressed within 4\u2009h, was given intranasally twice daily, 0.4\u2009ml in each nostril, initiated within 48\u2009h of life and continued until day 28.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Under continuous cardiorespiratory and neurointensive monitoring in neonatal intensive care, the therapy was well tolerated with no adverse events or side effects observed. The intervention proved to be feasible, treatment initiation was achieved within 48\u2009h in all enrolled neonates and was successfully continued by parents in the home setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>iFBM in neonates with moderate to severe HIE is safe and feasible in both inpatient and home settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>F-NEO -BRIGHT Study is the first clinical trial where intranasal fresh breast milk is administered to neonates with neonatal encephalopathy.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Intranasal fresh breast milk administration during the first month of life appears to be feasible, safe and well-tolerated both in hospital and in the home settings.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The full therapeutic potential of this treatment could be revealed by further research into long-term neurodevelopmental outcomes.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41390-026-04847-2","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:26:45Z","timestamp":1772558805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["F-NEO-BRIGHT: feasibility and safety of intranasal fresh breast milk in neonatal encephalopathy"],"prefix":"10.1038","author":[{"given":"Eszter","family":"Tarjanyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Jermendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miklos","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc A.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Szasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Nyilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unoke","family":"Meder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"4847_CR1","doi-asserted-by":"crossref","unstructured":"Chakkarapani, E., de Vries, L. S., Ferriero, D. M. & Gunn, A. J. Neonatal encephalopathy and hypoxic-ischemic encephalopathy: the state of the art. Pediatr. Res. 98, 2444\u20132458 (2025).","DOI":"10.1038\/s41390-025-03986-2"},{"key":"4847_CR2","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jpeds.2013.02.003","volume":"163","author":"A Perez","year":"2013","unstructured":"Perez, A. et al. Long-term neurodevelopmental outcome with hypoxic-ischemic encephalopathy. J. Pediatr. 163, 454\u2013459 (2013).","journal-title":"J. Pediatr."},{"key":"4847_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pcl.2012.10.002","volume":"60","author":"O Ballard","year":"2013","unstructured":"Ballard, O. & Morrow, A. L. Human milk composition: nutrients and bioactive factors. Pediatr. Clin. North Am. 60, 49\u201374 (2013).","journal-title":"Pediatr. Clin. North Am."},{"key":"4847_CR4","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1002\/stem.1188","volume":"30","author":"F Hassiotou","year":"2012","unstructured":"Hassiotou, F. et al. Breastmilk is a novel source of stem cells with multilineage differentiation potential. Stem Cells 30, 2164\u20132174 (2012).","journal-title":"Stem Cells"},{"key":"4847_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s13577-019-00251-7","volume":"32","author":"N Ninkina","year":"2019","unstructured":"Ninkina, N. et al. Stem cells in human breast milk. Hum. Cell 32, 223\u2013230 (2019).","journal-title":"Hum. Cell"},{"key":"4847_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/apa.13139","volume":"104","author":"BL Horta","year":"2015","unstructured":"Horta, B. L., Loret de Mola, C. & Victora, C. G. Breastfeeding and intelligence: a systematic review and meta-analysis. Acta Paediatr. 104, 14\u201319 (2015).","journal-title":"Acta Paediatr."},{"key":"4847_CR7","doi-asserted-by":"crossref","unstructured":"Strobel, K. M., Perez, K. M., Benjamin, H. & Hoban, R. Human milk as therapy: neurodevelopment and neonatal brain injury. Semin. Perinatol. 49, 152140 (2025).","DOI":"10.1016\/j.semperi.2025.152140"},{"key":"4847_CR8","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s13577-019-00320-x","volume":"33","author":"N Goudarzi","year":"2020","unstructured":"Goudarzi, N. et al. Comparative phenotypic characterization of human colostrum and breast milk-derived stem cells. Hum. Cell 33, 308\u2013317 (2020).","journal-title":"Hum. Cell"},{"key":"4847_CR9","doi-asserted-by":"publisher","first-page":"e51253","DOI":"10.1371\/journal.pone.0051253","volume":"8","author":"V Donega","year":"2013","unstructured":"Donega, V. et al. Intranasal mesenchymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement. PLoS ONE 8, e51253 (2013).","journal-title":"PLoS ONE"},{"key":"4847_CR10","doi-asserted-by":"crossref","unstructured":"McDonald, C. A. et al. Intranasal delivery of mesenchymal stromal cells protects against neonatal hypoxic(-)ischemic brain injury. Int. J. Mol. Sci. 20, 2449 (2019).","DOI":"10.3390\/ijms20102449"},{"key":"4847_CR11","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1038\/s41390-023-02721-z","volume":"94","author":"J .Kaps","year":"2023","unstructured":".Kaps, J. et al. Human preterm colostrum stimulates outgrowth in neurogenic tissue. Pediatr. Res. 94, 1906\u20131910 (2023).","journal-title":"Pediatr. Res."},{"key":"4847_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/10611860903318134","volume":"18","author":"SR Alcala-Barraza","year":"2010","unstructured":"Alcala-Barraza, S. R. et al. Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, AND NT-4 TO THE CNS. J. Drug Target 18, 179\u2013190 (2010).","journal-title":"J. Drug Target"},{"key":"4847_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00431-018-3279-7","volume":"178","author":"T Keller","year":"2019","unstructured":"Keller, T. et al. Intranasal breast milk for premature infants with severe intraventricular hemorrhage-an observation. Eur. J. Pediatr. 178, 199\u2013206 (2019).","journal-title":"Eur. J. Pediatr."},{"key":"4847_CR14","doi-asserted-by":"crossref","unstructured":"Hoban, R. et al. Feasibility of intranasal human milk as stem cell therapy in preterm infants with intraventricular hemorrhage. J. Perinatol. 44, 1652\u20131657 (2024).","DOI":"10.1038\/s41372-024-01982-8"},{"key":"4847_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41372-024-02147-3","volume":"45","author":"A Gallipoli","year":"2025","unstructured":"Gallipoli, A. et al. Outcomes after intranasal human milk therapy in preterm infants with intraventricular hemorrhage. J. Perinatol. 45, 202\u2013207 (2025).","journal-title":"J. Perinatol."},{"key":"4847_CR16","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1001\/archneur.1976.00500100030012","volume":"33","author":"HB Sarnat","year":"1976","unstructured":"Sarnat, H. B. & Sarnat, M. S. Neonatal encephalopathy following fetal distress. a clinical and electroencephalographic study. Arch. Neurol. 33, 696\u2013705 (1976).","journal-title":"Arch. Neurol."},{"key":"4847_CR17","unstructured":"Hungarian Central Statistical Office. Demographic Yearbook (K\u00f6zponti Statisztikai Hivatal, 2024)."},{"key":"4847_CR18","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJMoa0900854","volume":"361","author":"DV Azzopardi","year":"2009","unstructured":"Azzopardi, D. V. et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy.  N. Engl. J. Med. 361, 1349\u20131358 (2009).","journal-title":"N. Engl. J. Med."},{"key":"4847_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jpeds.2022.04.013","volume":"246","author":"U Meder","year":"2022","unstructured":"Meder, U. et al. Longitudinal analysis of amplitude-integrated electroencephalography for outcome prediction in hypoxic-ischemic encephalopathy. J. Pediatr. 246, 19\u201325 e15 (2022).","journal-title":"J. Pediatr."},{"key":"4847_CR20","doi-asserted-by":"publisher","first-page":"F34","DOI":"10.1136\/fn.72.1.F34","volume":"72","author":"L Hellstr\u00f6m-Westas","year":"1995","unstructured":"Hellstr\u00f6m-Westas, L., Ros\u00e9n, I. & Svenningsen, N. W. Predictive value of early continuous amplitude integrated eeg recordings on outcome after severe birth asphyxia in full term infants. Arch. Dis. Child. Fetal Neonatal Ed. 72, F34\u2013F38 (1995).","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"4847_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1542\/peds.2004-0863","volume":"115","author":"D Osredkar","year":"2005","unstructured":"Osredkar, D. et al. Sleep-wake cycling on amplitude-integrated electroencephalography in term newborns with hypoxic-ischemic encephalopathy. Pediatrics 115, 327\u2013332 (2005).","journal-title":"Pediatrics"},{"key":"4847_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jpeds.2017.09.043","volume":"192","author":"LC Weeke","year":"2018","unstructured":"Weeke, L. C. et al. A Novel magnetic resonance imaging score predicts neurodevelopmental outcome after perinatal asphyxia and therapeutic hypothermia. J. Pediatr. 192, 33\u201340 e32 (2018).","journal-title":"J. Pediatr."},{"key":"4847_CR23","doi-asserted-by":"crossref","unstructured":"Karcz, K., Walkowiak, M., Makuch, J., Olejnik, I. & Krolak-Olejnik, B. Non-nutritional use of human milk part 1: a survey of the use of breast milk as a therapy for mucosal infections of various types in Poland. Int. J. Environ. Res. Public Health 16, 1715 (2019).","DOI":"10.3390\/ijerph16101715"},{"key":"4847_CR24","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/sj.jp.7210742","volume":"22","author":"JA Blaymore Bier","year":"2002","unstructured":"Blaymore Bier, J. A., Oliver, T., Ferguson, A. & Vohr, B. R. Human milk reduces outpatient upper respiratory symptoms in premature infants during their first year of life. J. Perinatol. 22, 354\u2013359 (2002).","journal-title":"J. Perinatol."},{"key":"4847_CR25","doi-asserted-by":"crossref","unstructured":"Hachimi-Idrissi, S. Stem cell therapy in neurological disorders: promises and concerns. Explor. Neuroprot. Ther. 3, 346\u2013362 (2023).","DOI":"10.37349\/ent.2023.00055"},{"key":"4847_CR26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1161\/STROKEAHA.112.679092","volume":"44","author":"SY Ahn","year":"2013","unstructured":"Ahn, S. Y. et al. Mesenchymal stem cells prevent hydrocephalus after severe intraventricular hemorrhage. Stroke 44, 497\u2013504 (2013).","journal-title":"Stroke"},{"key":"4847_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3727\/096368916X694193","volume":"26","author":"WS Park","year":"2017","unstructured":"Park, W. S., Ahn, S. Y., Sung, S. I., Ahn, J. Y. & Chang, Y. S. Mesenchymal stem cells: The magic cure for intraventricular hemorrhage?. Cell Transpl. 26, 439\u2013448 (2017).","journal-title":"Cell Transpl."},{"key":"4847_CR28","volume":"14","author":"S Mane","year":"2022","unstructured":"Mane, S., Taneja, S., Madala, J. S., Agarkhedkar, S. & Khetan, M. Study of stem cells in human milk. Cureus 14, e23701 (2022).","journal-title":"Cureus"},{"key":"4847_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1749-0774.2010.00083.x","volume":"23","author":"S Patki","year":"2010","unstructured":"Patki, S., Kadam, S., Chandra, V. & Bhonde, R. Human breast milk is a rich source of multipotent mesenchymal stem cells. Hum. Cell 23, 35\u201340 (2010).","journal-title":"Hum. Cell"},{"key":"4847_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm6865","volume":"8","author":"JP Gleeson","year":"2022","unstructured":"Gleeson, J. P. et al. Profiling of mature-stage human breast milk cells identifies six unique lactocyte subpopulations. Sci. Adv. 8, eabm6865 (2022).","journal-title":"Sci. Adv."},{"key":"4847_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.21037\/pm.2019.02.02","volume":"2","author":"C Tang","year":"2019","unstructured":"Tang, C., Zhou, Q., Lu, C., Xiong, M. & Lee, S. Comparison and culturing different types of cells from fresh breast milk with different culture medium. Pediatr. Med. 2, 5\u20135 (2019).","journal-title":"Pediatr. Med."},{"key":"4847_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta25360","volume":"25","author":"C Gale","year":"2021","unstructured":"Gale, C. et al. Nutritional management in newborn babies receiving therapeutic hypothermia: two retrospective observational studies using propensity score matching. Health Technol. Assess. 25, 1\u2013106 (2021).","journal-title":"Health Technol. Assess."},{"key":"4847_CR33","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13052-022-01342-2","volume":"48","author":"Y Hu","year":"2022","unstructured":"Hu, Y. et al. Early versus delayed enteral nutrition for neonatal hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia: a randomized controlled trial. Ital. J. Pediatr. 48, 146 (2022).","journal-title":"Ital. J. Pediatr."},{"key":"4847_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2024.1357831","volume":"12","author":"S Costa","year":"2024","unstructured":"Costa, S. et al. Enteral nutritional strategy during therapeutic hypothermia: Who? When? What?. Front. Pediatr. 12, 1357831 (2024).","journal-title":"Front. Pediatr."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-04847-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-04847-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-04847-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:24:19Z","timestamp":1780669459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-04847-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":34,"alternative-id":["4847"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-04847-2","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to disclose. The Hungarian National Research, Development and Innovation Office had no role in the design and conduct of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed parental consent was obtained after a detailed verbal discussion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent statement"}}]}}